Pepijn Van de Ven

Pepijn van de Ven is a professor in Machine Learning, founding director of the Data-Driven Computer Engineering (D2iCE) research centre and course director of the National MSc in AI at the University of Limerick, Ireland. Pep, who is also a former president of the International Society for Research on Internet Interventions, specialises in the application of machine learning in mental health. He has been involved in various ground-breaking international projects making use of advanced ICT and data analytics in mental health interventions. Currently, he is the data analytics lead on two international projects: Personae funded by the Innovation Fund Denmark and COLMA funded by the UK National Institute for Health and Care Research.

Professor Catherine Haslam

Catherine Haslam is Professor of Clinical Psychology at the University of Queensland and the Director of SIGNify; a Centre that aims to translate the research of the Social Identity Groups Network to practice. She is a clinical academic whose work focuses on the social and cognitive impacts of identity-changing life transitions across the lifespan (associated with trauma, illness and recovery, transitions to study, workforce and sport retirement, and aging) and interventions that can be used to manage these. In particular, her research on social connectedness, health and well-being has contributed to a body of work on the social cure that has been published in two volumes — Social Cure: Identity, Health and Well-being (2012) and The New Psychology of Health: Unlocking the social cure (2018). This work has informed the Groups 4 Health program, a manualised social identity intervention that supports people to manage life change and its potential impact on both identity and health, and that will soon be published in the Oxford University Press Treatments that Work series.

Catherine Haslam is Professor of Clinical Psychology at the University of Queensland and a clinical academic whose work focuses on the social and cognitive impacts of identity-changing life transitions and interventions to manage these. Her research on social connectedness, health and well-being has contributed to a body of work on the social cure published in two volumes — Social Cure: Identity, Health and Well-being (2012) and The New Psychology of Health: Unlocking the social cure (2018). This work has informed the Groups 4 Health program, a manualised social identity intervention supporting people to manage their social connectedness to support health.

Professor Praveetha Patalay

Praveetha Patalay is Professor of Population Health and Wellbeing at University College London in the UK. Her research focuses on mental health through the lifecourse and drivers of health inequalities, with an interest in examining these across different contexts including time and place. She is interested in how we can achieve better health and wellbeing through our lives and the preventive measures and structural changes that might be needed to support this. She leads a multidisciplinary research group at UCL, and is working towards improving the diversity of disciplines, individuals and countries represented in mental health science with the goal to accelerate progress in improving population mental health.

Dr Paul Liknaitzky

Dr Paul Liknaitzky is Head of the Clinical Psychedelic Lab, and Senior Research Fellow within the Dept of Psychiatry at Monash University. He has played a central role in establishing the field of clinical psychedelic research in Australia, and is the Principal Investigator on a program of psychedelic trials. Liknaitzky leads the country’s largest and most experienced group of psychedelic researchers and clinicians, and collaborates with numerous psychedelic groups nationally and internationally.

In Australia, Paul established the first psychedelic lab, coordinated the first applied psychedelic therapist training program, obtained the first industry funding for psychedelic research, and co-convenes the Australasian Research Group on Psychedelic Science. Together with clinical and industry colleagues, he co-founded Australia’s first purpose-built psychedelic-assisted therapy clinic.

Paul’s work is focused on investigating novel applications for psychedelic therapies, translating evidence into best clinical practice, exploring under-examined risks, delivering next-generation therapist training, and improving access and affordability.

Dr Takayuki Enomoto

Professor Takayuki Enomoto is a specialist in Gynecologic Oncology, Gynecologic Pathology and Genetic Medicine. He graduated from Osaka University and commenced his career at the Osaka University Hospital. Since that time Professor Enomoto was Visting Fellow and Guest Researcher at the National Cancer Institute in the USA, Associate Professor at the Osaka University Graduate School of Medicine and Professor at the Department of Obstetrics and Gynecology at Osaka University Hospital. He was Professor and Chairman of the Department of Obstetrics and Gynecology at the Niigata University Graduate School of Medicine and Dental Services and is currently the Invited Professor at Osaka University Graduate School of Medine and Director of the Centre for Genetic Medicine, Itami City Hospital, Hyogo.

Professor Enomoto’s professional memberships include:

• East Asian Gynecologic Oncology Trial group
• Auditor, Immediate Past President, Japanese Gynecologic Oncology Group
• Corresponding Member, American Association for Cancer Research
• Active Member, American Society for Clinical Oncology
• Active Member, Society of Gynecologic Oncology
• Active Member, International Society for Gynecologic Cancer
• Honorary Member, Japanese Society of Obstetrics and Gynecology
• Honorary Member, Japanese Society of Gynecologic Oncology
• Honorary Member、Korean Scoiety of Gynecologic Oncology
• Auditor, Japanese Society of Gynecological Cancer Screening